Migraine Treatment Springfield Lakes: Expert Relief & Prevention 2025

Struggling with debilitating migraines? Migraines affect 4.9 million Australians, causing severe pain and disability. Professional diagnosis and targeted treatment can significantly reduce frequency and severity of attacks.

Understanding Migraines

Migraines are complex neurological disorders characterized by recurrent episodes of moderate to severe headache, often accompanied by nausea, vomiting, and sensitivity to light and sound.

Types of Migraines

Type	Characteristics	Duration	Prevalence
Migraine without Aura	Headache without warning signs	4-72 hours	80% of cases
Migraine with Aura	Visual/sensory disturbances before headache	5-60 minutes aura	20% of cases
Chronic Migraine	≥15 headache days per month	Variable	2-3% population
Menstrual Migraine	Linked to menstrual cycle	2-3 days	60% of women

Migraine Phases

Prodrome (Warning Phase):

Mood changes – irritability, depression, euphoria
Food cravings – specific food desires
Neck stiffness – muscle tension
Increased urination – fluid changes
Yawning – neurological changes

Aura Phase (20% of patients):

Visual symptoms – flashing lights, zigzag lines
Sensory symptoms – tingling, numbness
Speech disturbances – difficulty finding words
Motor symptoms – weakness (rare)

Headache Phase:

Unilateral pain – one-sided (can be bilateral)
Pulsating quality – throbbing sensation
Moderate to severe intensity – disabling pain
Nausea and vomiting – gastrointestinal symptoms
Photophobia and phonophobia – light/sound sensitivity

Postdrome (Recovery Phase):

Fatigue – feeling drained
Mood changes – depression or euphoria
Cognitive difficulties – concentration problems
Food cravings – appetite changes

Causes and Triggers

Neurobiological Mechanisms

Trigeminovascular system – activation of pain pathways
Cortical spreading depression – brain wave changes
Neurotransmitter imbalances – serotonin, dopamine dysfunction
Genetic factors – family history in 70% of cases
Hormonal influences – estrogen fluctuations

Common Triggers

Category	Triggers	Percentage Affected
Hormonal	Menstruation, contraceptives	60% women
Dietary	Aged cheese, wine, chocolate	30% patients
Environmental	Bright lights, strong odors	50% patients
Sleep	Too little/too much sleep	70% patients
Stress	Emotional/physical stress	80% patients
Weather	Barometric pressure changes	40% patients

Risk Factors

Gender – 3:1 female to male ratio
Age – peak onset 20-40 years
Family history – genetic predisposition
Hormonal factors – menstruation, pregnancy
Other conditions – depression, anxiety, sleep disorders

Diagnosis and Assessment

Clinical Criteria (ICHD-3)

Migraine without Aura:

At least 5 attacks
Headache lasting 4-72 hours
At least 2 of: unilateral, pulsating, moderate/severe intensity, aggravated by activity
At least 1 of: nausea/vomiting, photophobia and phonophobia

Migraine with Aura:

At least 2 attacks
Aura with at least 1 symptom: visual, sensory, speech/language, motor, brainstem, retinal
At least 3 characteristics: gradual spread, duration 5-60 minutes, unilateral, followed by headache

Diagnostic Tools

Assessment	Purpose	Details
Headache Diary	Pattern identification	3-month tracking recommended
MIDAS Scale	Disability assessment	Impact on daily activities
HIT-6	Headache impact	Quality of life measurement
Neuroimaging	Rule out secondary causes	MRI if red flags present

Red Flag Symptoms

Sudden severe headache – “thunderclap” onset
Headache with fever – possible infection
Neurological deficits – weakness, confusion
Progressive worsening – increasing frequency/severity
New headache after 50 – secondary cause concern

Treatment Approaches

Acute Treatment

First-Line Medications:

Medication	Dose	Onset	Effectiveness
Sumatriptan	50-100mg oral	30-60 min	60-80% relief
Rizatriptan	5-10mg oral	30-60 min	70-85% relief
Zolmitriptan	2.5-5mg oral	30-45 min	65-80% relief
Eletriptan	20-40mg oral	30-60 min	70-85% relief

Over-the-Counter Options:

Paracetamol – 1000mg, limited effectiveness
Ibuprofen – 400-600mg, anti-inflammatory
Aspirin – 900-1000mg, especially with caffeine
Combination products – paracetamol/aspirin/caffeine

Severe Attack Management:

Antiemetics – metoclopramide, domperidone
Corticosteroids – prednisolone for status migrainosus
IV treatments – for severe attacks or medication failure

Preventive Treatment

Indications for Prevention:

≥4 migraine days per month
Significant functional impairment
Medication overuse risk
Patient preference
Contraindications to acute treatments

First-Line Preventive Medications:

Class	Medication	Dose	Efficacy
Beta-blockers	Propranolol	80-240mg daily	50-60% reduction
Anticonvulsants	Topiramate	50-200mg daily	50-60% reduction
Tricyclics	Amitriptyline	25-150mg daily	50-70% reduction
Calcium Channel Blockers	Flunarizine	5-10mg daily	40-50% reduction

Novel Preventive Treatments:

CGRP antagonists – erenumab, fremanezumab
Botulinum toxin – for chronic migraine
Gepants – ubrogepant, rimegepant
Ditans – lasmiditan for acute treatment

Non-Pharmacological Treatments

Behavioral Interventions

Trigger identification – comprehensive diary keeping
Stress management – relaxation techniques, mindfulness
Sleep hygiene – consistent sleep schedule
Regular exercise – aerobic activity 3-4 times weekly
Dietary modifications – avoiding known triggers

Complementary Therapies

Therapy	Evidence Level	Recommendation
Acupuncture	High	Effective for prevention
Massage therapy	Moderate	May reduce frequency
Yoga/meditation	Moderate	Stress reduction benefits
Magnesium supplements	Moderate	400-600mg daily
Riboflavin (B2)	Moderate	400mg daily
Coenzyme Q10	Low-moderate	100-300mg daily

Lifestyle Modifications

Regular meal times – avoid skipping meals
Hydration – adequate fluid intake
Alcohol limitation – avoid known triggers
Smoking cessation – reduces attack frequency
Weight management – obesity increases risk

Specialized Treatment Approaches

Chronic Migraine Management

Diagnosis – ≥15 headache days per month for >3 months
Botulinum toxin injections – every 12 weeks
Combination therapy – multiple preventive agents
Medication overuse treatment – withdrawal protocols
Multidisciplinary approach – neurology, psychology, physiotherapy

Hormonal Migraine Management

Menstrual migraine – short-term prevention around menses
Pregnancy considerations – safe medication options
Contraceptive effects – may worsen or improve
Hormone replacement therapy – careful monitoring required
Perimenopausal changes – treatment adjustments needed

Status Migrainosus

Definition – migraine lasting >72 hours
Hospital treatment – IV medications, hydration
Breaking the cycle – aggressive intervention
Trigger identification – prevent recurrence
Follow-up care – preventive strategy review

Emergency Management

When to Seek Immediate Care

Sudden severe headache – different from usual pattern
Headache with fever and neck stiffness – possible meningitis
Headache with confusion – altered consciousness
Headache after head injury – trauma-related
Visual changes persisting – beyond typical aura

Emergency Treatment Options

IV triptan therapy – subcutaneous sumatriptan
Antiemetic treatment – severe nausea/vomiting
IV hydration – dehydration management
Corticosteroids – breaking prolonged attacks
Pain management – severe refractory pain

Complications and Prognosis

Migraine Complications

Status migrainosus – prolonged severe attack
Medication overuse headache – rebound headaches
Migrainous infarction – stroke during aura (rare)
Persistent aura – visual symptoms lasting >1 week
Seizures – rare complication

Long-term Outcomes

Chronic migraine development – 2.5% annual rate
Improvement with age – frequency often decreases
Treatment response – 70-80% achieve significant improvement
Quality of life – substantial improvement with proper treatment
Work productivity – reduced absenteeism and disability

Special Populations

Children and Adolescents

Different presentation – bilateral, shorter duration
School impact – attendance and performance issues
Treatment modifications – age-appropriate medications
Family involvement – education and trigger management
Developmental considerations – puberty effects

Pregnancy and Breastfeeding

Safety considerations – medication restrictions
Improvement patterns – often improve during pregnancy
Safe treatments – paracetamol, some preventives
Postpartum changes – return of pre-pregnancy patterns
Breastfeeding compatibility – limited medication options

Elderly Patients

Secondary causes – higher likelihood
Medication interactions – polypharmacy concerns
Comorbidities – cardiovascular considerations
Late-onset migraine – investigation required
Treatment modifications – dose adjustments needed

Take Action: Find Migraine Relief

Don’t let migraines control your life. Health Hub Springfield Lakes provides comprehensive migraine evaluation and treatment with the latest evidence-based approaches.

Book Your Migraine Assessment

Online booking: Available 24/7 at healthhubspringfieldlakes.com.au/
Phone booking: Call +61 7 3778 4888
Comprehensive evaluation: Detailed headache assessment
Treatment planning: Personalized migraine management

Address: 18 Springfield Lakes Blvd, Springfield Lakes QLD 4300
Your trusted partner for effective migraine treatment and neurological care.

Medical References

Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
Cameron C, Kelly S, Hsieh SC, et al. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Headache. 2015;55 Suppl 4:221-235.
Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930-945.
Australian Government Department of Health. Medicare Benefits Schedule: Chronic disease management. Canberra: Commonwealth of Australia; 2021.
Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Neurology. 2012;78(17):1337-1345.
Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349.
Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97(2):553-622.
National Institute for Health and Care Excellence. Headaches in over 12s: diagnosis and management. NICE guideline CG150. London: NICE; 2012.
MacGregor EA. Migraine in women. Continuum (Minneap Minn). 2015;21(4 Headache):1038-1051.
Dodick DW. A Phase-by-Phase Review of Migraine Pathophysiology. Headache. 2018;58 Suppl 1:4-16.

Medical Disclaimer: This information is for educational purposes and does not replace professional medical advice. If you’re experiencing frequent or severe migraines, please consult a healthcare professional promptly. Health Hub Springfield Lake’s medical team provides comprehensive, evidence-based care for all headache and migraine conditions.